General MedicationsINJECTIONGeneric

CYSTEINE HYDROCHLORIDE

Standard Dose

7.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview CYSTEINE HYDROCHLORIDE is listed in Drugs@FDA under application 019523 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CYSTEINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 7.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HOSPIRA Submission history Latest submission status date: 1986-10-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview CYSTEINE HYDROCHLORIDE is listed in Drugs@FDA under application 019523 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CYSTEINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 7.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HOSPIRA Submission history Latest submission status date: 1986-10-22 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.